Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding Cardinal Health’s opioid reserve details or segment margin shifts inside a 300-page filing can feel impossible. Cardinal Health’s SEC disclosures span distribution economics, medical-surgical inventory turns, and litigation footnotes that challenge even seasoned analysts.
Stock Titan turns that problem on its head. Our AI-powered summaries transform the Cardinal Health annual report 10-K simplified, break down every Cardinal Health quarterly earnings report 10-Q filing, and flag material changes in plain language. Real-time alerts push Cardinal Health Form 4 insider transactions to your dashboard the moment they hit EDGAR, so you never miss executive stock moves.
Whether you’re looking for Cardinal Health insider trading Form 4 transactions, a quick read on an unexpected 8-K material event explained, or need the numbers behind last quarter’s distribution margin in seconds, our platform delivers:
- AI-generated highlights that answer “What changed and why?”
- Side-by-side trend views for revenue, cash flow, and litigation accruals
- Clickable access to every filing type—from proxy statement executive compensation tables to shelf registrations
Spend less time decoding footnotes and more time acting on insights. Stock Titan provides Cardinal Health SEC filings explained simply, complete with earnings report filing analysis and Cardinal Health executive stock transactions Form 4 feeds. Understand Cardinal Health SEC documents with AI—without wading through hundreds of pages.
Cardinal Health Inc. reported an insider equity transaction by its Chief Legal/Compliance Officer. On 12/01/2025, the officer had 422 common shares disposed of in a transaction coded "F," which represents shares withheld to cover tax obligations related to restricted share units. The price used for the withholding was the closing share price of
After this tax withholding event and an adjustment for shares transferred under a domestic relations order, the officer beneficially owned 34,427 common shares directly. The filing notes that these share withholdings are administrative in nature and tied to equity compensation rather than an open-market sale.
Cardinal Health reported a routine insider transaction by the CEO of its PSS segment. On 12/01/2025, 551 common shares of Cardinal Health were withheld at a price of $212.26 per share to cover the executive’s tax obligations related to restricted share units. After this tax withholding, the reporting person directly beneficially owns 52,877 common shares of Cardinal Health.
Cardinal Health Inc. reported an insider share transaction by its Chief Accounting Officer. On 12/01/2025, the officer had 61 common shares withheld and disposed of to cover tax obligations related to restricted share units, at a reference price of $212.26 per share. After this tax-related withholding, the officer beneficially owned 3,495 Cardinal Health common shares directly. The filing is administrative in nature and reflects routine equity compensation and associated tax withholding.
Cardinal Health Inc. executive reports routine share withholding for taxes. The CEO of the GMPD segment filed a Form 4 reporting that on 12/01/2025, 595 Cardinal Health common shares were withheld at a price of $212.26 per share to cover tax obligations related to restricted share units. After this transaction, the reporting person beneficially owned 25,490 common shares directly. The filing notes that this was a non-open-market transaction classified under code "F," meaning it reflects shares withheld by the company rather than a discretionary sale in the market.
Cardinal Health (CAH) disclosed a director equity grant on a Form 4. On 11/05/2025, a director acquired 1,067 restricted share units (Transaction Code A) at a stated price of $0. These RSUs will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Following this award, the director beneficially owned 2,116 common shares, held directly. This filing reflects routine director compensation in equity and does not indicate an open-market purchase or sale.
Cardinal Health (CAH) reported an insider equity grant on a Form 4. A director acquired 1,067 common shares on 11/05/2025 via a restricted share unit award at $0. Following this grant, the director beneficially owns 2,116 shares, held directly.
The restricted share units will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier.
Cardinal Health (CAH) director reported an equity award. On 11/05/2025, the reporting person acquired 1,067 restricted share units at no cost. The award will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier. Following this grant, the director beneficially owned 7,536 common shares directly.
Cardinal Health (CAH) director reported a routine equity grant on 11/05/2025. The filing shows an acquisition of 1,067 common shares at $0, reflecting a grant of restricted share units. Following the transaction, the director’s beneficial ownership stands at 27,624 shares, held directly.
The restricted share units will vest on November 5, 2026, or if the 2026 Annual Meeting of Shareholders occurs earlier, on the meeting date.
Cardinal Health (CAH) reported an insider equity award. A company director acquired 1,702 common shares on 11/05/2025 via an award priced at $0, reflecting a grant of restricted share units. Following the transaction, the director beneficially owns 64,194 shares directly.
The restricted share units are scheduled to vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Cardinal Health (CAH) reported an insider equity grant. A director acquired 1,067 restricted share units on November 5, 2025, recorded at $0 per unit. Following the transaction, the reporting person beneficially owns 22,868 common shares, held directly. The RSUs will vest on November 5, 2026, or, if the 2026 Annual Meeting of Shareholders occurs before that date, they will vest on the meeting date.
FAQ
What is the current stock price of Cardinal Health (CAH)?
What is the market cap of Cardinal Health (CAH)?
